Markoorsig

The dermocosmetics market in Europe experienced a value of $6.48 billion in 2022 and is projected to reach $11.50 billion by 2028, growing at a CAGR of 10.03%.

Dermocosmetics are specifically formulated to maintain the beauty and health of the skin and hair. These products offer effective solutions for various skin issues such as excess sebum, redness, and dermatitis, while maintaining a reputation for safety and efficacy. They are often recommended by dermatologists or sold in healthcare settings. Consumers are increasingly shifting towards holistic products that address their specific skin problems in a safe, efficient, and comfortable manner.

Marksegmentasie

The market is segmented based on various factors, including product, verspreidingskanaal, gender, end-user, geography.

Segmentation by Product
Hair Care
Body Care
Anti-aging
Hygiene
Sun care
Ander

Segmentation by Distribution Channel
Pharmacy & Drug Stores
Online
Super Markets/Hyper Markets
Spesialiteitswinkels
Ander

Segmentation by Gender
Female
Male

Segmentation by End-User
Hospitals & Clinics
Medical Spas & Saloons
Individuals

Segmentation by Geography
Frankryk
Italië
Spanje
Duitsland
UK

The haircare segment accounted for 17.50% market share and was valued at $1.13 billion in 2022, experiencing a CAGR of 10.22%. The hair care industry offers a wide range of products including conditioners, sjampoe, oils, and masks, with both regional and national companies competing in the market. The demand for new and innovative hair care products is growing in Europe, leading to an increasing preference for dermocosmetic hair care products. Furthermore, the demand for dermocosmetic products is driven by the growing target population, as certain areas of the world, such as Europe, have a higher prevalence of hair loss, particularly male pattern baldness due to genetic factors.

In terms of distribution channel, the pharmacies & drugstores segment dominates the market with a 56.65% market share and a value of $3.67 billion in 2022, growing at a CAGR of 9.62%. Pharmacies are a preferred channel for purchasing dermocosmetic products due to their convenient locations. People trust that pharmacies offer original and safer products compared to department stores, which contributes to their popularity as a distribution channel.

In the end-user segment, hospitals & clinics hold the majority of the market with a 40.78% market share and a value of $2.64 billion in 2022, growing at a CAGR of 9.31%. Hospitals and skin clinics serve as primary care centers for aesthetic medical treatments, offering a comprehensive range of solutions for skin, hair, and body enhancement. Expertise and technological advancements available in these settings significantly drive market growth. Daarbenewens, dermatologist recommendations play a crucial role in consumers’ purchase decisions, with over 30% of skincare products being purchased based on their guidance. Skin clinics and offices continuously introduce new products and innovations, creating a positive impact on consumer interest in aesthetic procedures and subsequently influencing the purchase of dermocosmetic products.

Females are the primary consumers in the global cosmetics market. Approximately 60% of women purchase cosmetics on a quarterly or semi-annual basis, with 25% making frequent purchases. The dermocosmetics segment, with its promising results, has garnered significant attention. In Europe, over 40% of female consumers believe that natural ingredients are safer than mainstream ingredients in beauty products, driving the success of dermocosmetic products.

The French market presents excellent opportunities for dermocosmetic companies. The population in France is highly aware of cosmetic products and skin health, making it a key contributor to the success of luxury dermocosmetic products. Dermatologists in France play an essential role in prescribing the most effective products, further bolstering the market’s demand.

Mededingende landskap

L’Oréal is a prominent participant in the dermocosmetics market, holding a significant market share both globally and in the European region. Despite the challenges posed by the COVID-19 pandemic, the dermocosmetics segment exhibited positive growth, distinguishing itself as the only segment to do so. Currently, the competitive landscape of the dermocosmetics market in Europe is becoming more intense, with global players offering a wide range of diverse products.

Key companies profiled in this report include L’Oréal, Pierre Fabre, Beiersdorf, PUIG, Galderma, Avicanna, Bioderma, Biologique Recherche, Bioskin, Coty, Dermalogica, Dermophisi Ologioque, Embryolisse, HD Dermocosmetics, IDC Dermo, Infinitek, Nuxe, Rilastil, Uriage, Ziaja.

Key Questions Answered

What is the estimated valuation of the European Dermocosmetics Market?
The European Dermocosmetics Market was estimated to be valued at $6.48 billion in 2022.

What is the growth rate of the European Dermocosmetics Market?
The European Dermocosmetics Market has a growth rate of 10.0%, with an estimated value of $11.5 billion by 2028.

What is the projected size of the European Dermocosmetics Market?
The European Dermocosmetics Market is projected to have a worth of $11.5 billion by 2028.

Who are the key companies in the European Dermocosmetics Market?
Key companies in the European Dermocosmetics Market include L’Oréal, Pierre Fabre, Beiersdorf, PUIG, Galderma, Avicanna, Bioderma, Biologique Recherche, Bioskin, and Coty.